Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Metadata
Title
Safety of parathyroid hormone for the treatment of osteoporosis
Author
Paul D. Miller
Publication date
01-03-2008
Publisher
Current Science Inc.
Published in
Current Osteoporosis Reports / Issue 1/2008
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-008-0003-y

Other articles of this Issue 1/2008

Current Osteoporosis Reports 1/2008 Go to the issue

OriginalPaper

Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window

OriginalPaper

Osteonecrosis of the jaws and bisphosphonates

OriginalPaper

Vitamin D therapy

OriginalPaper

Web alert

OriginalPaper

Treatment of premenopausal women with low bone mineral density

OriginalPaper

Intravenous zoledronic acid for the treatment of osteoporosis